| Overall | Patients with probable OC | Patients without probable OC | P value |
---|---|---|---|---|
(n = 56) | (n = 8) | (n = 48) | ||
Age (years), mean (SD) | 67.6 ± 17.1 | 65.9 (20.0) | 69.3 (14.4) | 0.759 |
Female, n (%) | 18 (32.1) | 6 (75.0) | 12 (25.0) | 0.013†|
Malignancy, n (%) | 25 (44.6) | 5 (62.5) | 20 (41.7) | 0.282 |
Solid tumor | 20 (35.7) | 4 (50.0) | 16 (33.3) | 0.368 |
Hematological tumor | 5 (8.9) | 1 (12.5) | 4 (8.3) | 0.704 |
Diabetes mellitus, n (%) | 18 (32.1) | 3 (37.5) | 15 (31.3) | 0.727 |
Corticosteroids use, n (%) | 14 (25.0) | 3 (37.5) | 11 (22.9) | 0.384 |
Immunosuppressive drug use, n (%) | 15 (26.8) | 4 (50.0) | 11 (22.9) | 0.123b |
Neutropenia, n (%) | 5 (8.9) | 1 (12.5) | 4 (8.3) | 0.704 |
Recent systemic surgery (within 1 month), n (%) | 36 (64.3) | 5 (62.5) | 31 (64.6) | 0.909 |
IVH | 42 (75.0) | 6 (75.0) | 36 (75.0) | 1.000 |
Intravascular devices | 52 (92.9) | 7 (87.5) | 45 (93.8) | 0.534 |
Blood β-D-glucan (pg/mL), mean (SD) (n = 36) | 98.4 (161.5) |  |  |  |
Blood β-D-glucan > 20 pg/mL, n (%) (n = 36) | 16 (44.4) | 3 (60.0) | 13 (41.9) | 0.655 |
Heart failure, n (%) | 12 (21.4) | 1 (12.5) | 11 (22.9) | 0.514 |
Kidney failure, n (%) | 21 (37.5) | 2 (25.0) | 19 (39.6) | 0.436 |
Elevated liver enzymes, n (%) | 38 (67.9) | 4 (50.0) | 34 (70.8) | 0.252 |
Hypertension, n (%) | 21 (37.5) | 3 (37.5) | 18 (37.5) | 1.000 |
Anemia, n (%) | 49 (87.5) | 7 (87.5) | 42 (87.5) | 1.000 |
Thrombocytopenia, n (%) | 24 (42.9) | 2 (25.0) | 22 (45.8) | 0.282 |
Collagen-related disease, n (%) | 7 (12.5) | 1 (12.5) | 6 (12.5) | 1.000 |
Previous history of ophthalmic surgery, n (%) | 16 (28.6) | 1 (12.5) | 15 (31.3) | 0.299 |
Candida species, n (%) | ||||
 Candida albicans | 23 (41.1) | 7 (87.5) | 16 (33.3) | 0.018a†|
 Candida parapsilosis | 14 (25.0) | 1 (12.5) | 13 (27.1) | 0.392 a |
 Candida glabrata | 7 (12.5) | 0 (0.0) | 7 (14.6) |  |
 Candida tropicalis | 7 (12.5) | 0 (0.0) | 7 (14.6) |  |
 Candida krusei | 3 (5.4) | 0 (0.0) | 3 (6.3) |  |
 Other Candida species | 2 (3.6) | 0 (0.0) | 2 (4.2) |  |